Cephalexin for Streptococcal Infections
Cephalexin is an appropriate alternative antibiotic for Group A streptococcal pharyngitis in penicillin-allergic patients (excluding those with immediate hypersensitivity reactions), dosed at 20 mg/kg/dose twice daily (maximum 500 mg/dose) for 10 days in children, or 500 mg four times daily in adults. 1, 2
Indications for Cephalexin in Streptococcal Infections
Group A Streptococcal Pharyngitis
Cephalexin is not a first-line agent for strep throat. Penicillin or amoxicillin remains the drug of choice due to narrow spectrum, proven efficacy, safety, and low cost 2. However, cephalexin is strongly recommended as an alternative for penicillin-allergic patients who do not have immediate-type hypersensitivity reactions 1, 2.
Critical caveat: Avoid cephalexin in patients with immediate hypersensitivity to penicillin (anaphylaxis, angioedema, urticaria) due to cross-reactivity risk 1.
Skin and Soft Tissue Infections
For nonpurulent cellulitis (no drainage/abscess), cephalexin is appropriate empiric therapy targeting β-hemolytic streptococci and methicillin-susceptible Staphylococcus aureus (MSSA) 3, 4. The 2014 IDSA guidelines recommend cephalexin 500 mg four times daily in adults or 25-50 mg/kg/day in 3-4 divided doses in children for 5-10 days 3, 4.
For impetigo involving streptococci and staphylococci, cephalexin 250 mg four times daily (adults) or 25-50 mg/kg/day in 3-4 divided doses (children) is effective 3, 4.
Dosing Regimens
Adults
- Streptococcal pharyngitis: 500 mg every 12 hours for 10 days 5
- Skin/soft tissue infections: 250 mg every 6 hours OR 500 mg every 12 hours 5
- More severe infections: Up to 4 g daily in divided doses 5
Pediatric Patients
- Streptococcal pharyngitis: 20 mg/kg/dose twice daily (maximum 500 mg/dose) for 10 days 1, 2
- Skin/soft tissue infections: 25-50 mg/kg/day in 3-4 divided doses 3, 4
- Alternative for pharyngitis: Total daily dose may be divided every 12 hours for patients >1 year 5
Important: For β-hemolytic streptococcal infections, therapeutic dosing must continue for at least 10 days to prevent rheumatic fever 5.
Evidence Quality
The recommendation for cephalexin in strep pharyngitis carries strong recommendation with high-quality evidence from IDSA guidelines 1, 2. Multiple randomized controlled trials demonstrate cephalexin achieves bacteriologic cure rates of 90-97% for Group A streptococcal pharyngitis, comparable or superior to penicillin 6, 7. A double-blind study of 525 children showed cephalexin had lower combined treatment failure rates (10%) compared to penicillin (19%) 6.
Twice-daily dosing is equally effective as four-times-daily dosing for streptococcal pharyngitis, improving adherence 8, 9. Studies demonstrate no significant difference in bacteriologic failure rates between bid (7.3%) and qid (5.3%) regimens 8.
Clinical Considerations
- Duration: Always complete the full 10-day course for streptococcal pharyngitis to prevent rheumatic fever complications 2, 5
- Resistance: Cephalexin resistance in Group A streptococcus remains rare, unlike macrolides where resistance varies geographically 1
- Compliance advantage: Twice-daily dosing improves adherence compared to penicillin's four-times-daily requirement 8
- Suspension storage: After reconstitution, refrigerate and discard after 14 days 5